QuorumCivic. Hidden in plain sight Get the app
Bill intelligence

Federal biological data platform opens to researchers—with industry influence and geopolitical gatek

S. 4770 — Web of Biological Data Act of 2026 · Filed by Todd Young (R-IN) · 3 cosponsors · Introduced Jun 11, 2026 · Referred to committee

72%
Transparency
Typical bill: 82%
18/100
Hidden-provision risk
Typical bill: 15/100
Public Research Infrastructure

Your members of Congress

Enter a ZIP to see where your representative and both senators stood on this bill.

Looked up on this device — your ZIP is never stored on our servers.

What it does

This bill directs the Department of Energy to award a grant to a National Laboratory to build a centralized online platform—the 'Web of Biological Data'—that aggregates biological research data funded by the federal government and makes it accessible to researchers via a single entry point. The platform will use artificial intelligence and advanced computational tools to help scientists discover and analyze biological datasets, with tiered security controls and restrictions on sharing data with certain countries.

Why we flagged it

The bill establishes a federally funded, centralized data platform to consolidate and share biological research data across government agencies and with academic and industry partners. Its core function is infrastructure development for scientific research, not regulation, appropriation, or commemoration.

What the text implies

  • The bill grants the Secretary of Energy broad discretion to determine which countries are excluded from data sharing ('adversarial countries and countries that do not participate in reciprocal data sharing'), creating potential for geopolitical data gatekeeping without explicit congressional criteria.
  • Industry cost-sharing agreements and partnerships may create financial incentives for private companies to influence data curation, access policies, or research priorities, potentially biasing the platform toward commercially valuable datasets.

The full analysis lists 5 implications of this text.

Who stands to gain

biotechnology companies; pharmaceutical firms; AI/machine learning vendors

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
Quorum analysis of the full bill text · 119th Congress · public record